A clinical trial carried out in Mali and the United States of America has shown that a new Ebola vaccine developed under the auspices of the World Health Organisation has promises. The study report published in the Lancet Infectious Diseases Journal says the vaccine protects people who are close to Ebola patients such as health workers and relatives and thus can break the transmission chain and hence curtail the spread of the disease.

The study was conducted by the University of Maryland, United States of America. 

Related Posts

 Lack of sleep is related to gestational diabetes, high blood sugar levels in pregnant women

 Kellogg’s to cut sugar in kids’ cereals by up to 40%

 India: Two doctors fired for mistakenly declaring newborn dead

 Drop in blood pressure levels in elderly adults an indicative of early death: Study

 ‘Zero tolerance’ plan eyed for plastic pollution

 Philippines launches probe into dengue vaccine scare

No Comments

Leave a Comment